Evidence map›Paper›PMID 39415572›Full record

ReviewAnti-inflammatory & anti-allergy agents in medicinal chemistry2025

A Review on Phytochemical Constituents used as Current Treatment Strategies for Neurodegenerative Disease.

Krishna Jee, Rishabh Gaur, Jai Prakash Kadian, Km Meenu, Muhammad Murtaza, Sanjay Kumar Verma, Bharati Malik, Km Shilpa

Abstract readReview
PubMed Publisher
In one paragraph

Review in Anti-inflammatory & anti-allergy agents in medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Krishna JeeDepartment of Pharmaceutical Chemistry, CARE College of Pharmacy (Chinmaya Advance Research Education), Rohalki, Kishanpur, Bahadrabad, Haridwar (U.K.), India.
Rishabh GaurDepartment of Pharmacology, Institute of Pharmaceutical Research, GLA University (U.P.), Mathura, India.ORCID 0000-0003-4707-6371
Jai Prakash KadianDepartment of Pharmacology, Shobit University, Gango (U.P.), Saharanpur, India.
Km MeenuDepartment of Pharmacology, Himalayan Institute of Pharmacy and Research, Dehradun (U.K.), India.
Muhammad MurtazaDepartment of Pharmacology, Glocal University, Saharanpur (U.P.), India.
Sanjay Kumar VermaDepartment of Pharmacology, Motherhood University, Roorkee, (U.K.), India.
Bharati MalikDepartment of Pharmacognosy, Translam Institute of Pharmacy Education and Research, Meerut, (U.P.), India.
Km ShilpaDepartment of Pharmaceutics, Roorkee College of Pharmacy, Roorkee (U.K.), India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In today's time, a diversity of neurodegenerative diseases that widely affect the CNS causing insufficiency in particular brain processes such as memory, mobility, and cognition due to the moderate loss of CNS neurons. This review emphasizes different phytochemical constituents used widely for the prevention or treatment of various neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD). Berberin (BBR), which is an isoquinoline class of alkaloid and isolated from the plant

Indexed as

Neurodegenerative DiseasesPhytochemicalsAlzheimer DiseaseAnimalsHumansPhytochemicalsAcetylcholinesterasealzheimeramyloid β plaquesberberinisorhynchophyllineparkinsonpiperin.α-synuclein expressionμ-opioid receptor

Identifiers

PMID39415572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.